fda glp-1 news november 2025 weight loss drugs are back in the US approves new oral weight-loss

Muscle mass, bone density, and connective tissue load all shift under GLP-1 therapy

Importantly, the improved menstrual regularity seen in women with PCOS on semaglutide, where 80 percent of responsive patients normalized their cycles, suggests that the medication can be profoundly positive for reproductive and sexual health in the right population

There are a few limitations with this analysis

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about individual variations in GLP-1 receptor and glucose-insulin signaling pathways

Within the first year after birth: See your primary care team and get a cardiovascular baseline reading that includes blood pressure, cholesterol, blood glucose, height and weight